Autophagy activators have been shown to reduce the levels of misfolded and aggregated proteins, mitigating the spreading of tau and neuronal loss [11,12,13,14,15,16,17], although whether autophagy impairment is a contributor or a consequence of tauopathy remains unclear [18,19]. The gene discussed is MAPT; the disease is tauopathy.